Medine.co.uk

Curofen 50 Mg/G Oral Powder For Pigs

Issued: December 2015

AN: 00843/2014

SUMMARY OF PRODUCT CHARACTERISTICS


1. NAME OF THE VETERINARY MEDICINAL PRODUCT


Curofen50 mg/g oral powderforpigs


[Fendoral 50 mg/g oral powder for pigs (Belgium)]


2. QUALITATIVE AND QUANTITATIVE COMPOSITION


Each g contains:


Active substance:


Fenbendazole 50 mg


Excipients:


For the full list of excipients, see section 6.1.


3. PHARMACEUTICAL FORM


Oral powder.

Awhitepowder.


4. CLINICAL PARTICULARS


4.1 Target species


Pigs.


4.2 Indications for use, specifying the target species


Forthetreatment ofbenzimidazolesusceptiblematureand immature(L4) forms ofthefollowing nematodes of thegastrointestinal and respiratory tracts ofpigs:


Hyostrongylus rubidus (red stomach worm)


Oesophagostomumspp. (nodularworms)


Ascaris suum(eel worm)

Trichuris suis (whip worm)

Metastrongylus apri (Lungworm)


4.3 Contraindications


Do not use in case of hypersensitivity to the active substance or to any of the excipients.


4.4 Special warnings for each target species


Careshouldbetakentoavoidthefollowingpracticesbecausetheyincreasetheriskofdevelopmentofresistanceand could ultimately resultin ineffectivetherapy:



Suspected clinical cases ofresistanceto anthelmintics should befurtherinvestigated using appropriatetests (e.g.Faecal Egg CountReduction Test). Wheretheresultsofthetest(s)strongly suggest resistanceto aparticularanthelmintic, an anthelminticbelonging to anotherpharmacological class and having adifferent modeofaction should beused.


4.5 Special precautions for use


Special precautions for use in animals


Not applicable.


Special precautions to be taken by the person administering the veterinary medicinal product to animals


This product may cause hypersensitivity (allergy) reactions. People with known hypersensitivity to fenbendazole should avoid contact with the veterinary medicinal product.


Avoid skin contact when handling this product.


When handling or mixing, care should be taken to avoid direct contact with the skin and inhalation of any dust by wearing protective clothing, including impervious gloves and a face-mask. It is recommended to use either a disposable half-mask respirator conforming to European Standard EN 149 or a non-disposable respirator to European Standard EN 140 with a filter to EN 143.


Wash hands and all exposed skin after use.


Other Precautions


The veterinary medicinal product should not be allowed to enter surface waters as it has harmful effects on aquatic organisms.


4.6 Adverse reactions (frequency and seriousness)


None known.


4.7 Use during pregnancy, lactation or lay


Theproduct can beused in pregnant or lactating sows.


4.8 Interaction with other medicinal products and other forms of interaction


None known.


4.9 Amounts to be administered and administration route


For oral administration by adding to small quantities of feed for immediate consumption by individual pigs.


Individual Treatment – single dose

The recommended therapeutic dose is 5 mg fenbendazole per kg bodyweight as a single dose individual treatment which is equivalent to 1g of product per 10kg bodyweight or 5g of product per 50 kg bodyweight or 20g of product per 200 kg bodyweight.


To ensure the correct dosage and to avoid possible under-dosing, the bodyweight and the amount of product to be administered should be determined as accurately as possible. To accurately measure the correct amount of product, a suitably calibrated weighing scale should be used.

The recommended amount of veterinary medicinal product should be added to a small quantity of the estimated daily amount of food for each individual animal in a bucket or a similar container and mixed thoroughly prior to being offered for immediate consumption.

Medicated feed should be freshly prepared before administration.

Part-consumed feed must be disposed of with other waste feed and not given to other animals.


Dosing table:


Pig Bodyweight (kg)

Amount (g)

of product

50 kg

5g

100 kg

10g

150 kg

15g

200 kg

20g


For use in individual pigs on farms where only a small number of pigs are to receive the veterinary medicinal product. Larger groups should be treated with medicated feeding stuff manufactured using an appropriate anthelmintic premix.


Treatment for specific infections

For the treatment of Trichuris suis, it is recommended that the dosage is divided and administered over seven days.


4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary


None known.


4.11 Withdrawal period


Meat and offal: 6 days.


5. PHARMACOLOGICAL PROPERTIES


Pharmacotherapeutic group: Anthelmintics, benzimidazole derivatives – fenbendazole.

ATCvet code: QP52AC13.


5.1 Pharmacodynamic properties


Fenbendazole is an anthelmintic (wormer) belonging to the benzimidazole-carbamate group. It acts by binding to beta-tubulin, thereby inhibiting the polymerisation of tubulin to microtubules and subsequently interfering with energy metabolism.


5.2 Pharmacokinetic particulars


Fenbendazoleis poorly solublein waterand consequently is poorly absorbed when administered orally. The main breakdown products arethesulphoxide(oxfendazole)and sulphone.


6. PHARMACEUTICAL PARTICULARS


6.1 List of excipients


GlucoseMonohydrate

Colloidal anhydrous silica


6.2 Incompatibilities


In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.


6.3 Shelf life


Shelf life of the veterinary medicinal product as packaged for sale: 3 years

Shelf life after first opening the immediate packaging: 28 days


6.4. Special precautions for storage


Store in a dry place.

Store in the original container in order to protect from light.


6.5 Nature and composition of immediate packaging

200 g and 1kg bag composed of clear low density polyethylene (LDPE) laminated with metallised polyester.

1 kg bag composed of clear low density polyethylene (LDPE).


5 x 200g LDPE laminated bags in a cardboard box

1 kg LDPE laminated bag

1 kg LDPE bag inside a white polypropylene container


Not all pack sizes may be marketed


6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products


Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. The product should not enter water courses as this may be dangerous for aquatic organisms.


7. MARKETING AUTHORISATION HOLDER


Univet Ltd.

Tullyvin

Cootehill

Co. Cavan

Ireland


8. MARKETING AUTHORISATION NUMBER


Vm 05150/4004


9. DATE OF FIRST AUTHORISATION


04 December 2015


10. DATE OF REVISION OF THE TEXT


December 2015





Approved: 04 December 2015


Page 5 of 5